|
Satellite symposium 1 |
May. 10 (17:00~18:00) | 좌장: 김선우 |
| Sponsored by MSD |
|
|
이병완 (연세의대) |
Clinical experience with sitagliptin in Korean subjects with type2 diabetes |
|
|
|
Satellite symposium 2 |
May. 10 (17:00~18:00) | 좌장: 이형우 |
| Sponsored by LG |
|
|
이은정 (성균관의대 내과) |
New clinical experience of gemigliptin |
|
|
|
Breakfast symposium 1 |
May. 11 (07:30~08:30) | 좌장: 강성구 |
| Sponsored by 릴리 |
|
|
박석원 (차의과학대 내과) |
What is the optimal insulin treatment when the patient is not adequately controlled with basal insulin? |
|
|
|
Breakfast symposium 2 |
May. 11 (07:30~08:30) | 좌장: 안유배 |
| Sponsored by 사노피 |
|
|
김대중 (아주의대 내과) |
Can we reduce CV complication by targeting normal glucose levels? |
|
|
|
Breakfast symposium 3 |
May. 12 (07:30~08:30) | 좌장: 이현철 |
| Sponsored by 베링거인겔하임 |
|
|
최성희 (서울의대 내과) |
Why do we need another the DPP-4 inhibitors? |
|
|
|
|
Breakfast symposium 4
| May. 12 (07:30~08:30) | 좌장: 이광우 |
| Sponsored by 노바티스 |
|
|
오태근 (충북의대 내과) |
Comparison of vildagliptin-metformin and glimepiride-metformin treatments in type 2 diabetic patients |
|
|
|
Luncheon symposium 1 |
May. 11 (13:00~14:30) | 좌장: 최동섭 |
| Sponsored by 애보트 |
|
|
홍은경 (한림의대 내과) |
Optimizing diabetic dyslipidemia beyond traditional risk factors: is there a microvascular benefit? |
|
|
|
Luncheon symposium 2 |
May. 11 (13:00~14:30) | 좌장: 최영길 |
| Sponsored by 아스트라제네카 |
|
|
박정현 (인제의대 내과) |
What are the advantages of ONGLYZA(saxagliptin) for the treatment of type 2 diabetes mellitus? |
|
|
|
Luncheon symposium 3 |
May. 11 (13:00~14:30) | 좌장: 조정구 |
| Sponsored by 중외 |
|
|
서지아 (고려의대) |
The new reliable options to treat dyslipidemia with diabetes mellitus |
|
|
|
Luncheon symposium 4 |
May. 11 (13:00~14:30) | 좌장: 박성우 |
| Sponsored by 다케다 |
|
|
박철영 (성균관의대 내과) |
Type 2 diabetes and cardiovascular risk: a multifactorial approach |
|
|
|
Luncheon symposium 5 |
May. 12 (12:10~13:30) | 좌장: 김영건 |
| Sponsored by 한독 |
|
|
전성완 (순천향의대 내과) |
Management of diabetic peripheral neuropathy |
|
|
|
Luncheon symposium 6 |
May. 12 (12:10~13:30) | 좌장: 궁성수 |
| Sponsored by 노보노디스크 |
|
|
유순집 (가톨릭의대) |
Insulin treatment strategies by new clinical trials |
|
|
|
Luncheon symposium 7 |
May. 12 (12:10~13:30) | 좌장: 허갑범 |
| Sponsored by 대웅 |
|
|
조영민 (서울의대 내과) |
Efficacy and safety of sitagliptin in various clinical settings of type 2 diabetes |
|
|
|